Efficacy, Safety, and Tolerability of Darifenacin in Patients Aged > 65 Years With Overactive Bladder

PHASE4CompletedINTERVENTIONAL

Enrollment

400

Participants

Timeline

Start Date

April 30, 2005

Study Completion Date

June 30, 2006

Conditions

Overactive Bladder

Interventions

DRUG

Darifenacin

Darifenacin 7,5 mg tablets once daily with the possibility to up-titrate to 15 mg once daily

DRUG

Placebo

Placebo tablet once daily with sham titration

Trial Locations (1)

Scott Department of Urology Baylor College of Medicine, Houston